CAH sees FY 2027 EPS growth guidance of 13%-15%
CAH reported strong FY 2026 results tied to specialty and generics growth and guided FY 2027 EPS growth of 13%-15%. The company cited acquisition integration, cost management and targeted M&A.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.